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Analysis of ATP2C1 Gene Mutation in 10 Unrelated Japanese
Families with Hailey±Hailey Disease
To the Editor:
Hailey±Hailey disease (HHD) is an autosomal dominant chronic
blistering disease, which is histologically characterized by kerati-
nocyte acantholysis and epidermal cleft formation (Burge, 1992).
The disease typically presents in middle age as crusted erosions or
circinate plaques in sites exposed to friction such as the neck,
axillae, groin, and perineum. Recently, the gene ATP2C1 has been
identi®ed as defective in HHD. It has been suggested that HHD is
caused by a haploinsuf®ciency of this new Ca2+-ATPase (Hu et al,
2000; Sudbrak et al, 2000). So far 33 different mutations in the
ATP2C1 gene from 35 unrelated HHD families have been
identi®ed in the literature. Mutations in 42 cases have yet to be
identi®ed out of a total of 77 so far analyzed. In this study, we
screened the genomic DNA of the ATP2C1 gene in 10 unrelated
Japanese families with HHD, and found ®ve mutations including
four novel mutations of ATP2C1.
Ten genetically unrelated Japanese patients with HHD were
analyzed in this study (Table I). There were nine males and one
female. They have had no family history of HHD or other skin
diseases.
Genomic DNA was extracted from peripheral blood leukocytes
using a standard procedure. Pairs of primers spanning all 28 exons
and ¯anking intronic splice sites of the ATP2C1 gene were used to
amplify the genomic DNA. Aliquots of the PCR products were
analyzed on 2% agarose gel electrophoresis, and 8 ml of the samples
were used for conformation sensitive gel electrophoresis (CSGE)
analysis (Ganguly et al, 1993). Subsequently, PCR products
containing the heteroduplexes were subject to direct sequencing
by an ABI automated sequencer (PE Applied Biosystems, Foster
City, CA). Alternatively, in samples where heteroduplexes were
not detected by CSGE analysis, all the PCR products were subject
to direct sequencing.
CSGE analysis of PCR fragments detected three abnormal shifts
in electrophoretic mobility. Sequencing of these PCR products
revealed three different mutations in three cases (Table I). One
457C®T base substitution resulted in a nonsense mutation in exon
7 of case 1 (Fig 1A). This mutation was veri®ed by a DdeI
digestion. This was identical to a mutation as reported by Hu et al
(2000). Also detected was a C490F missense mutation in exon 17
resulting from a 1469G®T substitution in case 2 (Fig 1B). As no
enzymatic veri®cation could test this mutation, we performed
direct sequencing of exon 17 in 50 normal control subjects to verify
this mutation. The mutation 2460delG created a shift in the reading
frame and resulted in a downstream PTC at exon 25 in case 10
(Fig 1D). In the other seven cases, we conducted direct sequencing
of the entire coding sequence of the ATP2C1 gene, because we
could not detect any heteroduplex bands. One L584P missense
mutation was found in case 3 (Fig 1C), and was con®rmed by Nci
I digestion. A splice site mutation occurred in case 10 at the site of a
guanine of a conserved GT nucleotide within the donor splice site
of intron 12 (Fig 1E). This mutation would alter the correct
splicing of exon 12 and result in PTC at eight nucleotides
downstream from the donor splice site, although the precise
transcription product is unknown as mRNA was unavailable from
this case. We were unable to detect any nucleotide changes in ®ve
cases despite direct sequencing of the entire genomic coding
sequence of the ATP2C1 gene (Table I).
We have analyzed ATP2C1 mutations in 10 genetically
unrelated Japanese families with HHD showing typical clinical
and histopathologic features of this condition. We have found
®ve attributable mutations including four novel mutations
comprising two missense mutations (C490F and L584P), one
deletion (2460delG), and one splice-site mutation (1259+1g®a).
We could not determine any ATP2C1 mutations in ®ve of the
10 HHD families after direct sequencing of the entire coding
region of ATP2C1 genomic DNA, including the exon±intron
Figure 1. Mutation analysis in HHD families.
(A) Mutation in case 1. A 457C®T base
substitution resulted in a nonsense mutation in
exon 7. (B) Mutaion in case 2. A 1469G®T
substitution resulted in a C490F missense
mutation in exon 17. (C) Mutation in case 3. A
1751T®C substitution resulted in a L584P
missense mutation in exon 19. (D) Mutation in
case 4. A 2460delG created a shift in the reading
frame and resulted in a downstream PTC in exon
25. (E) Mutation in case 5. A 1259+1g®a splice
site mutation resulted in skipping exon 12.
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boundaries. All of the cases analyzed have typical features of
HHD suggesting several possible causes of this discrepancy.
First, we cannot detect large deletions spanning the entire
coding region of ATP2C1 with our detection system. Second,
we cannot detect intronic mutations, mutations in the promoter
regions, or mutations in the 3¢-untranslated region. The fact
that Hu et al (2000) detected only 21 mutations out of a
possible 61 HHD cases using the same primer sets supports our
®ndings.
Among the ®ve families in which we could determine muta-
tions, those with missense mutations (cases 2 and 3) and the one
with a nonsense mutation in exon 25 (case 4) were predicted to
produce abnormal ATP2C1 protein. These three cases showed
early clinical symptoms (before the age of 40) compared with those
with nonsense mutations in the 5¢ proximal exons (cases 1 and 5).
In cases 1 and 5, severely reduced amounts of ATP2C1 protein are
expected to be found because of ``nonsense-mediated mRNA
decay'' (Frischmeyer and Dietz, 1999; Hentze and Kulozik, 1999).
mRNA that has a nonsense mutation at the 5¢ proximal region
would result in breakage because of the mechanism that is called
``nonsense-mediated mRNA decay'', and no abnormal truncated
protein would be translated. On the other hand, mRNA that has a
missense mutation or a nonsense mutation close to the end of the
gene could be translated, and abnormal protein could interfere
the action of normal ATP2C1 protein. Although HHD has
been considered to be the result of haploinsuf®ciency of the
ATP2C1 gene, the dominant negative effects of abnormal
ATP2C1 protein might also contribute to the disease phenotype.
Our data provide a signi®cant addition to the HHD mutation
database and will contribute further to the understanding of HHD
genotype/phenotype correlations and to the pathogenesis of this
disease.
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Unusual Pemphigus Phenotype in the Presence of a Dsg1 and
Dsg3 Autoantibody Pro®le
To the Editor:
Pemphigus foliaceus (PF) and pemphigus vulgaris (PV) are two
autoimmune blistering diseases presenting with distinct but related
antigenic speci®city and histopathologic features (Amagai, 1995;
Stanley, 1995; Suter et al, 1998; Anhalt and Diaz, 2001). In both
diseases, the target antigens are transmembrane components of
desmosomal junctions that mediate strong intercellular adhesion
between keratinocytes (Green and Gaudry, 2000). In PF, the
autoantibodies target desmoglein (Dsg) 1, and in PV Dsg3 (Amagai,
1995; Stanley, 1995; Suter et al, 1998; Anhalt et al, 2001). Whereas
the autoantibodies bind to all sites within strati®ed squamous
epithelia where the antigen is expressed, blister formation is
restricted to speci®c locations. In PF, split formation occurs in the
subcorneal zone of the epidermis where Dsg1 is present without
Dsg3, and in PV blisters form between basal and suprabasal layers of
initially mucous membranes where Dsg3 is present without Dsg1
Table I. ATP2C1 mutations in patients with HHD
Patient Age/sex
Age of
onset Mutationa
Location of
mutation
Nucleotide
changeb Consequence
1 55/M 51 R153X exon 7 457C®T nonsense
2 54/M 38 C490F exon 17 1469G®T missense
3 70/M 40 L584P exon 19 1751T®C missense
4 58/M 40 2460delG exon 25 CATGTT®CATTT franeshift (PTC+5 aa)
5 62/F 55 1259+1g®a intron 12 TGGgta®TGGata skip exon 12 (PTC)
6 45/M 30 ND
7 45/M 20 ND
8 33/M 27 ND
9 44/M 30 ND
10 63/M 62 ND
aNumbering of the amino acids refers to the peptide sequence.
bNumbering of the nucleotides refers to ATP2C1 cDNA sequence, with the ®rst nucleotide of ATG initiation codon as 1. Bases in the exons are denoted by uppercase
letters and bases in the introns by lowercase letters. PTC+n aa indicates that the premature termination codon is ''n'' amino acids downstream of the mutation. X, stop co-
don; ND, ``not detected''; PTC, premature termination codon.
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